Yes, the Herald Sun newspaper article is correct. This is Phase 1 and 2a (safety, tolerability and efficacy) of a world-first trial injecting parthenogenetic stem cells into the brains of 12 humans. Phase 1 and 2a is being conducted over a 12 month + period, the first candidate underwent surgery in July 2016 and the second is now being prepped for surgery Sept/Oct. The trial is being conducted at the Royal Melbourne Hospital under the leadership of neurologist Dr Andrew Evans and neurosurgeon Dr Girish Nair. Phase 3 and 4 double-blind placebo is expected to follow if the outcome of Phase 1 and 2a is successful.